Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/14426
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | VAN DER SPEETEN, Kurt | - |
dc.contributor.author | Stuart, O. Anthony | - |
dc.contributor.author | Sugarbaker, Paul H. | - |
dc.date.accessioned | 2012-11-30T12:52:29Z | - |
dc.date.available | 2012-11-30T12:52:29Z | - |
dc.date.issued | 2012 | - |
dc.identifier.citation | SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 21 (4), p. 577-597 | - |
dc.identifier.issn | 1055-3207 | - |
dc.identifier.uri | http://hdl.handle.net/1942/14426 | - |
dc.description.abstract | Peritoneal surface malignancy is a common manifestation of intra-abdominal malignancies. Systemic chemotherapy offers no long-term survival and poor quality of life for these patients in their terminal stages of disease. By contrast, cytoreductive surgery combined with perioperative intraperitoneal and intravenous chemotherapy has resulted in encouraging clinical results. Further improvements should come from both clinical phase II/III studies and pharmacologic research. This article reviews the current pharmacologic data and controversies regarding the perioperative intraperitoneal and intravenous application of chemotherapy. | - |
dc.language.iso | en | - |
dc.publisher | W B SAUNDERS CO-ELSEVIER INC | - |
dc.subject.other | Peritoneal metastases; Pharmacology; Intraperitoneal chemotherapy; Intravenous chemotherapy | - |
dc.subject.other | Oncology; Surgery; peritoneal metastases; pharmacology; intraperitoneal chemotherapy; intravenous chemotherapy | - |
dc.title | Pharmacology of Perioperative Intraperitoneal and Intravenous Chemotherapy in Patients with Peritoneal Surface Malignancy | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 597 | - |
dc.identifier.issue | 4 | - |
dc.identifier.spage | 577 | - |
dc.identifier.volume | 21 | - |
local.format.pages | 22 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | [Van der Speeten, Kurt] Ziekenhuis Oost Limburg, Dept Surg Oncol, B-3600 Genk, Belgium. [Van der Speeten, Kurt] Univ Hasselt, Res Grp Oncol, Dept Med, Hasselt, Belgium. [Stuart, O. Anthony; Sugarbaker, Paul H.] Washington Hosp Ctr, Washington Canc Inst, Dept Surg Oncol, Washington, DC 20010 USA. | - |
local.publisher.place | PHILADELPHIA | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
dc.bibliographicCitation.oldjcat | A1 | - |
dc.identifier.doi | 10.1016/j.soc.2012.07.013 | - |
dc.identifier.isi | 000310403300007 | - |
item.fulltext | No Fulltext | - |
item.accessRights | Closed Access | - |
item.validation | ecoom 2013 | - |
item.contributor | VAN DER SPEETEN, Kurt | - |
item.contributor | Stuart, O. Anthony | - |
item.contributor | Sugarbaker, Paul H. | - |
item.fullcitation | VAN DER SPEETEN, Kurt; Stuart, O. Anthony & Sugarbaker, Paul H. (2012) Pharmacology of Perioperative Intraperitoneal and Intravenous Chemotherapy in Patients with Peritoneal Surface Malignancy. In: SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 21 (4), p. 577-597. | - |
crisitem.journal.issn | 1055-3207 | - |
crisitem.journal.eissn | 1558-5042 | - |
Appears in Collections: | Research publications |
SCOPUSTM
Citations
32
checked on Sep 3, 2020
WEB OF SCIENCETM
Citations
37
checked on Sep 27, 2024
Page view(s)
66
checked on Sep 6, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.